131 related articles for article (PubMed ID: 21131205)
1. Design, synthesis, and biological evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine and its analogs as a novel class of anticancer agents.
Chen W; Seefeldt T; Young A; Zhang X; Guan X
Bioorg Med Chem; 2011 Jan; 19(1):287-94. PubMed ID: 21131205
[TBL] [Abstract][Full Text] [Related]
2. N‑acetyl-S-(p-chlorophenylcarbamoyl)cysteine induces mitochondrial-mediated apoptosis and suppresses migration in melanoma cells.
Chen W; Jiang Z; Zhang X; Feng J; Ling Y
Oncol Rep; 2015 Nov; 34(5):2547-56. PubMed ID: 26351874
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of N-acetyl-S-(p-chlorophenylcarbamoyl)cysteine as an irreversible inhibitor of mammalian thioredoxin reductase1.
Chen W; Jiang Z; Lin N; Zheng Z; Chen Z; Zhang X; Guan X
J Enzyme Inhib Med Chem; 2016; 31(2):229-35. PubMed ID: 25778746
[TBL] [Abstract][Full Text] [Related]
4. Glutathione and mercapturic acid conjugates of sulofenur and their activity against a human colon cancer cell line.
Guan X; Hoffman BN; McFarland DC; Gilkerson KK; Dwivedi C; Erickson AK; Bebensee S; Pellegrini J
Drug Metab Dispos; 2002 Mar; 30(3):331-5. PubMed ID: 11854154
[TBL] [Abstract][Full Text] [Related]
5. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, single-crystal and preliminary antitumor activity of novel arenesulfonylimidazolidin-2-ones.
Abdel-Aziz AA; El-Azab AS; El-Subbagh HI; Al-Obaid AM; Alanazi AM; Al-Omar MA
Bioorg Med Chem Lett; 2012 Mar; 22(5):2008-14. PubMed ID: 22318157
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, Activity and Docking Study of Sorafenib Analogs Bearing Sulfonylurea Unit.
Wu C; Wang M; Tang Q; Luo R; Chen L; Zheng P; Zhu W
Molecules; 2015 Oct; 20(10):19361-71. PubMed ID: 26512636
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of some new pyrazoline substituted benzenesulfonylureas as potential antiproliferative agents.
Rathore P; Yaseen S; Ovais S; Bashir R; Yaseen R; Hameed AD; Samim M; Gupta R; Hussain F; Javed K
Bioorg Med Chem Lett; 2014 Apr; 24(7):1685-91. PubMed ID: 24630557
[TBL] [Abstract][Full Text] [Related]
10. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
11. A novel class of achiral seco-analogs of CC-1065 and the duocarmycins: design, synthesis, DNA binding, and anticancer properties.
Kupchinsky S; Centioni S; Howard T; Trzupek J; Roller S; Carnahan V; Townes H; Purnell B; Price C; Handl H; Summerville K; Johnson K; Toth J; Hudson S; Kiakos K; Hartley JA; Lee M
Bioorg Med Chem; 2004 Dec; 12(23):6221-36. PubMed ID: 15519165
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative and phenotype-transforming antitumor agents derived from cysteine.
Glenn MP; Kahnberg P; Boyle GM; Hansford KA; Hans D; Martyn AC; Parsons PG; Fairlie DP
J Med Chem; 2004 Jun; 47(12):2984-94. PubMed ID: 15163181
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
[TBL] [Abstract][Full Text] [Related]
14. Novel diarylsulfonylurea derivatives as potent antimitotic agents.
Kim S; Park JH; Koo SY; Kim JI; Kim MH; Kim JE; Jo K; Choi HG; Lee SB; Jung SH
Bioorg Med Chem Lett; 2004 Dec; 14(24):6075-8. PubMed ID: 15546733
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
17. Sulfonimidamide analogs of oncolytic sulfonylureas.
Toth JE; Grindey GB; Ehlhardt WJ; Ray JE; Boder GB; Bewley JR; Klingerman KK; Gates SB; Rinzel SM; Schultz RM; Weir LC; Worzalla JF
J Med Chem; 1997 Mar; 40(6):1018-25. PubMed ID: 9083492
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
19. 1,2,3-triazole tethered Indole-3-glyoxamide derivatives as multiple inhibitors of 5-LOX, COX-2 & tubulin: Their anti-proliferative & anti-inflammatory activity.
Naaz F; Preeti Pallavi MC; Shafi S; Mulakayala N; Shahar Yar M; Sampath Kumar HM
Bioorg Chem; 2018 Dec; 81():1-20. PubMed ID: 30081353
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor evaluation of novel cyclic arylsulfonylureas: ADME-T and pharmacophore prediction.
El-Deeb IM; Bayoumi SM; El-Sherbeny MA; Abdel-Aziz AA
Eur J Med Chem; 2010 Jun; 45(6):2516-30. PubMed ID: 20236733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]